Found: 16
Select item for more details and to access through your institution.
Association of Inadequately Controlled Disease and Disease Severity With Patient-Reported Disease Burden in Adults With Atopic Dermatitis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Patient-Reported Outcomes in COVID-19 Treatment with Monoclonal Antibodies Reveal Benefits in Return to Usual Activities.
- Published in:
- Infectious Diseases & Therapy, 2024, v. 13, n. 8, p. 1861, doi. 10.1007/s40121-024-01013-1
- By:
- Publication type:
- Article
Effectiveness of Subcutaneous Casirivimab and Imdevimab in Ambulatory Patients with COVID-19.
- Published in:
- Infectious Diseases & Therapy, 2022, v. 11, n. 6, p. 2125, doi. 10.1007/s40121-022-00691-z
- By:
- Publication type:
- Article
Patient-reported outcomes labeling for oncology drugs: Multidisciplinary perspectives on current status and future directions.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 01, doi. 10.3389/fphar.2022.1031992
- By:
- Publication type:
- Article
Economic Evaluation of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults.
- Published in:
- Dermatology & Therapy, 2017, v. 7, n. 4, p. 493, doi. 10.1007/s13555-017-0201-6
- By:
- Publication type:
- Article
Reliability and Validity of an Instrument of COVID-19 Patient-Reported Symptoms in Outpatients.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 10, p. e2239053, doi. 10.1001/jamanetworkopen.2022.39053
- By:
- Publication type:
- Article
Effectively Leveraging RWD for External Controls: A Systematic Literature Review of Regulatory and HTA Decisions.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 2, p. 325, doi. 10.1002/cpt.2914
- By:
- Publication type:
- Article
Regulatory and HTA Considerations for Development of Real‐World Data Derived External Controls.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 2, p. 303, doi. 10.1002/cpt.2913
- By:
- Publication type:
- Article
Development and content validation of the Symptoms Evolution of COVID-19: a patient-reported electronic daily diary in clinical and real-world studies.
- Published in:
- Journal of Patient-Reported Outcomes, 2022, v. 6, n. 1, p. 1, doi. 10.1186/s41687-022-00448-9
- By:
- Publication type:
- Article
Cost-effectiveness of PCSK9 Inhibitor Therapy.
- Published in:
- 2016
- By:
- Publication type:
- Letter
Recent trends in exposure to secondhand smoke in the United States population.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Patient‐reported outcomes with cemiplimab monotherapy for first‐line treatment of advanced non–small cell lung cancer with PD‐L1 of ≥50%: The EMPOWER‐Lung 1 study.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 1, p. 118, doi. 10.1002/cncr.34477
- By:
- Publication type:
- Article
Correction to: The Patient Matters in the End(point).
- Published in:
- 2022
- By:
- Publication type:
- corrected article
The Patient Matters in the End(point).
- Published in:
- 2022
- By:
- Publication type:
- journal article
Donepezil Is Associated with Delayed Nursing Home Placement in Patients with Alzheimer's Disease.
- Published in:
- Journal of the American Geriatrics Society, 2003, v. 51, n. 7, p. 937, doi. 10.1046/j.1365-2389.2003.51306.x
- By:
- Publication type:
- Article
Efficacy of Donepezil on Maintenance of Activities of Daily Living in Patients with Moderate to Severe Alzheimer's Disease and the Effect on Caregiver Burden.
- Published in:
- Journal of the American Geriatrics Society, 2003, v. 51, n. 6, p. 737, doi. 10.1046/j.1365-2389.2003.51260.x
- By:
- Publication type:
- Article